Chronic kidney disease and coronary artery vulnerable plaques

Clinical Journal of the American Society of Nephrology

Volumn 6, Issue 12, 2011, Pages 2792-2798

  Wada, Mitsuru ^a   Ueda, Yasunori ^a   Higo, Tomoaki ^b   Matsuo, Koshi ^a   Nishio, Mayu ^a   Hirata, Akio ^a   Asai, Mitsutoshi ^a   Nemoto, Takayoshi ^a   Kashiyama, Toshikazu ^a   Murakami, Ayaka ^a   Kashiwase, Kazunori ^a   Kodama, Kazuhisa ^a  

^a OSAKA POLICE HOSPITAL   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; ORAL ANTIDIABETIC AGENT; TICLOPIDINE;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ANTIHYPERTENSIVE THERAPY; ARTICLE; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY BLOOD VESSEL; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PREVALENCE; RISK FACTOR; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

ACUTE CORONARY SYNDROME; AGED; CHRONIC DISEASE; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY DISEASES; LOGISTIC MODELS; MALE; MIDDLE AGED;

EID: 83155175930     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.06780711     Document Type: Article

References (17)

1. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296-1305, 2004
2. Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, McAlister F, Garg AX: Chronic kidney disease and mortality risk: A systematic review. J Am Soc Nephrol 17: 2034-2047, 2006
3. Hage FG, Venkataraman R, Zoghbi GJ, Perry GJ, DeMattos AM, Iskandrian AE: The scope of coronary heart disease in patients with chronic kidney disease. J Am Coll Cardiol 53: 2129-2140, 2009
4. Yamamoto S, Kon V: Mechanisms for increased cardiovascular disease in chronic kidney dysfunction. Curr Opin Nephrol Hypertens 18: 181-188, 2009
5. Nanayakkara PW, Gaillard CA: Vascular disease and chronic renal failure: New insights. Neth J Med 68: 5-14, 2010
6. Ohtani T, Ueda Y, Mizote I, Oyabu J, Okada K, Hirayama A, Kodama K: Number of yellow plaques detected in a coronary artery is associated with future risk of acute coronary syndrome: Detection of vulnerable patients by angioscopy. J Am Coll Cardiol 47: 2194-2200, 2006
7. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130: 461-470, 1999
8. Ueda Y, Nanto S, Komamura K, Kodama K: Neointimal coverage of stents in human coronary arteries observed by angioscopy. J Am Coll Cardiol 23: 341-346, 1994
9. Ueda Y, Asakura M, Yamaguchi O, Hirayama A, Hori M, Kodama K: The healing process of infarct-related plaques. Insights from 18 months of serial angioscopic follow-up. J Am Coll Cardiol 38: 1916-1922, 2001
10. Ueda Y, Ohtani T, Shimizu M, Hirayama A, Kodama K: Assessment of plaque vulnerability by angioscopic classification of plaque color. Am Heart J 148: 333-335, 2004
11. Kubo T, Imanishi T, Takarada S, Kuroi A, Ueno S, Yamano T, Tanimoto T, Matsuo Y, Masho T, Kitabata H, Tanaka A, Nakamura N, Mizukoshi M, Tomobuchi Y, Akasaka T: Implication of plaque color classification for assessing plaque vulnerability: A coronary angioscopy and optical coherence tomography investigation. JACC Cardiovasc Interv 1: 74-80, 2008
12. Sanidas EA, Maehara A, Mintz GS, Kashiyama T, Guo J, Pu J, Shang Y, Claessen B, Dangas GD, Leon MB, Moses JW, Stone GW, Ueda Y: Angioscopic and virtual histology intravascular ultrasound characteristics of culprit lesion morphology underlying coronary artery thrombosis. Am J Cardiol 107: 1285-1290, 2011
13. Tanaka A, Imanishi T, Kitabata H, Kubo T, Takarada S, Tanimoto T, Kuroi A, Tsujioka H, Ikejima H, Ueno S, Kataiwa H, Okouchi K, Kashiwaghi M, Matsumoto H, Takemoto K, Nakamura N, Hirata K, Mizukoshi M, Akasaka T: Morphology of exertion-triggered plaque rupture in patients with acute coronary syndrome: An optical coherence tomography study. Circulation 118: 2368-2373, 2008
14. Angiolillo DJ, Bernardo E, Capodanno D, Vivas D, Sabaté M, Ferreiro JL, Ueno M, Jimenez-Quevedo P, Alfonso F, Bass TA, Macaya C, Fernandez-Ortiz A: Impact of chronic kidney disease on platelet function profiles in diabetes mellitus patients with coronary artery disease taking dual antiplatelet therapy. J Am Coll Cardiol 55: 1139-1146, 2010
15. Shepherd J, Kastelein JJ, Bittner V, Deedwania P, Breazna A, Dobson S, Wilson DJ, Zuckerman A, Wenger NK; TNT (Treating to New Targets) Investigators: Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: The TNT (Treating to New Targets) study. J Am Coll Cardiol 51: 1448-1454. 2008
16. Hirayama A, Saito S, Ueda Y, Takayama T, Honye J, Komatsu S, Yamaguchi O, Li Y, Yajima J, Nanto S, Takazawa K, Kodama K: Qualitative and quantitative changes in coronary plaque associated with atorvastatin therapy. Circ J 73: 718-725, 2009
17. Cirillo M: Evaluation of glomerular filtration rate and of albuminuria/ proteinuria. J Nephrol 23: 125-132, 2010